TREVENA, INC. Forms 3, 4 and 5: Stock Options
Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 30 rows in 2017. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.
- 2017-08-28: Reporting owner Limongelli John M; Form 4; Security Employee Stock Option (Right to Buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2017-08-28: Reporting owner Lark Michael W.; Form 4; Security Employee Stock Option (Right to Buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2017-08-28: Reporting owner Habib Yacoub; Form 4; Security Employee Stock Option (Right to Buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2017-08-28: Reporting owner Cuca Roberto; Form 4; Security Employee Stock Option (Right to Buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
| Transaction date | Reporting owner | Form | Security | Transaction | Shares | Price | Price that day | Filing |
|---|---|---|---|---|---|---|---|---|
| 2017-08-28 | Limongelli John M Officer (Sr. VP,General Counsel & CAO) | 4 | Employee Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +66,000 66,000 owned after | $2.37 exercise price | 2017-08-29 | |
| 2017-08-28 | Lark Michael W. Officer (Sr. VP, Research & CSO) | 4 | Employee Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +66,000 66,000 owned after | $2.37 exercise price | 2017-08-29 | |
| 2017-08-28 | Habib Yacoub Officer (SVP, Bus Dev & Corp Planning) | 4 | Employee Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +66,000 66,000 owned after | $2.37 exercise price | 2017-08-29 | |
| 2017-08-28 | Cuca Roberto Officer (Sr. VP and CFO) | 4 | Employee Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +66,000 66,000 owned after | $2.37 exercise price | 2017-08-29 | |
| 2017-08-28 | Bourdow Carrie L. Officer (SVP, Chief Commercial Officer) | 4 | Employee Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +66,000 66,000 owned after | $2.37 exercise price | 2017-08-29 | |
| 2017-08-28 | GOWEN MAXINE Director, Officer (President & CEO) | 4 | Employee Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +225,000 225,000 owned after | $2.37 exercise price | 2017-08-29 | |
| 2017-05-17 | Nunn Jason Raleigh Director | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +15,000 15,000 owned after | $3.08 exercise price | 2017-06-06 | |
| 2017-05-17 | Yanni Barbara Director | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +15,000 15,000 owned after | $3.08 exercise price | 2017-06-06 | |
| 2017-05-17 | Phillips Anne M. Director | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +15,000 15,000 owned after | $3.08 exercise price | 2017-06-06 | |
| 2017-05-17 | MOULDER LEON O JR Director | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +15,000 15,000 owned after | $3.08 exercise price | 2017-06-06 | |
| 2017-05-17 | McHugh Julie Director | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +15,000 15,000 owned after | $3.08 exercise price | 2017-06-06 | |
| 2017-05-17 | Koppel Adam Director | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +15,000 15,000 owned after | $3.08 exercise price | 2017-06-06 | |
| 2017-05-17 | DOUGHERTY MICHAEL R Director | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +15,000 15,000 owned after | $3.08 exercise price | 2017-06-06 | |
| 2017-03-02 | Soergel David Officer (Sr. VP,Clinical Dev. & CMO) | 4 | Employee Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +91,000 91,000 owned after | $4.13 exercise price | 2017-03-03 | |
| 2017-03-02 | Limongelli John M Officer (Sr. VP,General Counsel & CAO) | 4 | Employee Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +91,000 91,000 owned after | $4.13 exercise price | 2017-03-03 | |
| 2017-03-02 | Lark Michael W. Officer (Sr. VP, Research & CSO) | 4 | Employee Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +91,000 91,000 owned after | $4.13 exercise price | 2017-03-03 | |
| 2017-03-02 | Habib Yacoub Officer (SVP, Bus Dev & Corp Planning) | 4 | Employee Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +91,000 91,000 owned after | $4.13 exercise price | 2017-03-03 | |
| 2017-03-02 | Cuca Roberto Officer (Sr. VP and CFO) | 4 | Employee Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +113,750 113,750 owned after | $4.13 exercise price | 2017-03-03 | |
| 2017-03-02 | Bourdow Carrie L. Officer (SVP, Chief Commercial Officer) | 4 | Employee Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +91,000 91,000 owned after | $4.13 exercise price | 2017-03-03 | |
| 2017-03-02 | GOWEN MAXINE Director, Officer (President & CEO) | 4 | Employee Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +303,000 303,000 owned after | $4.13 exercise price | 2017-03-03 | |
| 2017-02-23 | GOWEN MAXINE Director, Officer (President & CEO) | 4 | Employee Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −4,074 0 owned after | $0.68 exercise price | 2017-02-27 | |
| 2017-02-23 | GOWEN MAXINE Director, Officer (President & CEO) | 4 | Employee Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −106,329 0 owned after | $0.68 exercise price | 2017-02-27 | |
| 2017-02-10 | Lark Michael W. Officer (Sr. VP, Research & CSO) | 4 | Employee Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −12,815 48,362 owned after | $0.68 exercise price | 2017-02-14 | |
| 2017-01-06 | Soergel David Officer (Sr. VP,Clinical Dev. & CMO) | 4 | Employee Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +55,000 55,000 owned after | $6.61 exercise price | 2017-01-06 | |
| 2017-01-06 | Limongelli John M Officer (Sr. VP,General Counsel & CAO) | 4 | Employee Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +55,000 55,000 owned after | $6.61 exercise price | 2017-01-06 | |
| 2017-01-06 | Lark Michael W. Officer (Sr. VP, Research & CSO) | 4 | Employee Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +55,000 55,000 owned after | $6.61 exercise price | 2017-01-06 | |
| 2017-01-06 | Habib Yacoub Officer (SVP, Bus Dev & Corp Planning) | 4 | Employee Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +55,000 55,000 owned after | $6.61 exercise price | 2017-01-06 | |
| 2017-01-06 | Cuca Roberto Officer (Sr. VP and CFO) | 4 | Employee Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +55,000 55,000 owned after | $6.61 exercise price | 2017-01-06 | |
| 2017-01-06 | Bourdow Carrie L. Officer (SVP, Chief Commercial Officer) | 4 | Employee Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +55,000 55,000 owned after | $6.61 exercise price | 2017-01-06 | |
| 2017-01-06 | GOWEN MAXINE Director, Officer (President & CEO) | 4 | Employee Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +175,000 175,000 owned after | $6.61 exercise price | 2017-01-06 |